JPMorgan Chase (JPM) director defers annual stock grant into shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
JPMorgan Chase director Phebe N. Novakovic reported receiving 913.5251 shares of common stock on January 20, 2026, as an acquisition coded "A". The filing explains this was a deferral of her annual stock grant, which will be paid in JPMorgan Chase shares when her service as a director ends. After this transaction, she beneficially owned 13,258.911 shares directly. The filing also notes an additional 45 shares of common stock held indirectly through her spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
NOVAKOVIC PHEBE N
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 913.525 | $306.505 | $280K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 13,258.911 shares (Direct);
Common Stock — 45 shares (Indirect, By Spouse)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did JPM (JPM) report for Phebe N. Novakovic?
Phebe N. Novakovic reported an acquisition of 913.5251 shares of JPMorgan Chase common stock on January 20, 2026, coded as transaction type "A".
What does the Form 4 footnote say about the JPM (JPM) director grant?
The footnote states the transaction is a deferral of the director’s annual stock grant, payable in JPMorgan Chase shares upon termination of her service as a director.
Was the JPM (JPM) director’s transaction a purchase on the open market?
No. The Form 4 describes the transaction as a deferral of an annual stock grant, not an open‑market purchase, and codes it as an acquisition of stock.